These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 21801222)

  • 1. Do oral iron supplements have any role in dialysis patients?
    Mariani LH; Berns JS
    Semin Dial; 2011; 24(4):385-7. PubMed ID: 21801222
    [No Abstract]   [Full Text] [Related]  

  • 2. The therapeutic equivalence of oral and intravenous iron in renal dialysis patients.
    Strickland ID; Chaput de Saintonge DM; Boulton FE; Francis B; Roubikova J; Waters JI
    Clin Nephrol; 1977 Feb; 7(2):55-7. PubMed ID: 321170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Iron supplementation in the non-dialysis chronic kidney disease (ND-CKD) patient: oral or intravenous?
    Macdougall IC
    Curr Med Res Opin; 2010 Feb; 26(2):473-82. PubMed ID: 20014980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral or parenteral iron therapy in haemodialysis patients?
    Winney RJ; Swainson CP; Parker AC; Bone JM; Robson JS
    Proc Eur Dial Transplant Assoc; 1977; 14():184-91. PubMed ID: 600955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Anemia in chronic hemodialysis; comparative value of iron therapy administered by oral and intravenous routes].
    Ducros J; Benas P; Salvadori JM; Olmer M
    J Urol Nephrol (Paris); 1977 Sep; 83(9):735-8. PubMed ID: 926237
    [No Abstract]   [Full Text] [Related]  

  • 6. Erythropoietin with oral iron in peritoneal and hemodialysis patients. A comparison in an inner city population.
    Raja R; Bloom E; Goldstein M; Johnson R
    ASAIO J; 1993; 39(3):M578-80. PubMed ID: 8268603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Serum ferritin during hemodialysis. II: Outline for iron therapy].
    Marco Franco JE; Alarcón Zurita A; Morey Molina A; Pizá Buñola C; Bestard Palmer J; Mairata Bosch S; Galmés Llodra A; Dalmau Diana M
    Rev Clin Esp; 1982 Jan; 164(1):11-4. PubMed ID: 7071397
    [No Abstract]   [Full Text] [Related]  

  • 8. Reduction in recombinant human erythropoietin doses by the use of chronic intravenous iron supplementation.
    Sadjadi SA
    Am J Kidney Dis; 1995 Dec; 26(6):1000-1. PubMed ID: 7503060
    [No Abstract]   [Full Text] [Related]  

  • 9. Maintenance therapy with intravenous iron in hemodialysis patients receiving erythropoietin.
    Kotaki M; Uday K; Henriquez M; Blum S; Dave M
    Clin Nephrol; 1997 Jul; 48(1):63-4. PubMed ID: 9247787
    [No Abstract]   [Full Text] [Related]  

  • 10. Lessons from NKF-DOQI: iron management.
    Van Wyck DB
    Semin Nephrol; 2000 Jul; 20(4):330-4. PubMed ID: 10928334
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparative effects of erythropoietin with oral iron in peritoneal dialysis and hemodialysis patients.
    Raja R; Bloom E; Johnson R
    Adv Perit Dial; 1993; 9():177-80. PubMed ID: 8105918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of oral versus intravenous iron therapy in predialysis patients of chronic renal failure receiving recombinant human erythropoietin.
    Aggarwal HK; Nand N; Singh S; Singh M; Hemant ; Kaushik G
    J Assoc Physicians India; 2003 Feb; 51():170-4. PubMed ID: 12725261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Letter: Iron treatment of dialysis patients.
    Chaput De Saintonge DM; Boulton FE; Strickland ID
    Br Med J; 1975 May; 2(5966):337. PubMed ID: 1131535
    [No Abstract]   [Full Text] [Related]  

  • 14. Role of oral iron in the management of long-term hemodialysis patients.
    Lenga I; Lok C; Marticorena R; Hunter J; Dacouris N; Goldstein M
    Clin J Am Soc Nephrol; 2007 Jul; 2(4):688-93. PubMed ID: 17699483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A trial of oral iron in dialysis patients.
    Strickland ID; Chaput de Saintonge DM; Boulton FE; Brain AJ; Goodwin FJ; Marsh FP; Zychova Z
    Clin Nephrol; 1974; 2(1):13-7. PubMed ID: 4595978
    [No Abstract]   [Full Text] [Related]  

  • 16. [Treatment with intravenous iron and infection in hemodialysis].
    Fernández-Gallego J; Ramos B; López de Novales E
    Nefrologia; 2002; 22(1):89-90. PubMed ID: 11987694
    [No Abstract]   [Full Text] [Related]  

  • 17. Changes in non-transferrin-bound iron (NTBI) in pregnant women on iron supplements.
    Baron J; Ben-David G; Hallak M
    Eur J Obstet Gynecol Reprod Biol; 2008 Oct; 140(2):281-2. PubMed ID: 18304722
    [No Abstract]   [Full Text] [Related]  

  • 18. Reduction in recombinant human erythropoietin doses by the use of chronic intravenous iron supplementation.
    Perazella MA
    Am J Kidney Dis; 1995 Dec; 26(6):1000; author reply 1001. PubMed ID: 7503059
    [No Abstract]   [Full Text] [Related]  

  • 19. Parenteral iron, yes but how?
    Bayes B; Bonal J; Juncå J
    Nephrol Dial Transplant; 1998 Jan; 13(1):230. PubMed ID: 9481753
    [No Abstract]   [Full Text] [Related]  

  • 20. Supervised intradialytic oral iron administration during erythropoietin therapy.
    Fourtounas C; Koutsikos D; Dalamangas A; Kapetanaki A; Kostoglou M; Agroyannis B; Tzanatos H; Kopelias I; Bosiolis B
    Nephrol Dial Transplant; 1996 Jul; 11(7):1485-6. PubMed ID: 8815424
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.